Single-cell RNA sequencing of antigen presenting cell subsets (APCs), a central source of IFNs, showed critical defects in the response to type I IFN in severe COVID-19 patients, suggesting that dysfunctional IFN production, receptor expression and downstream ISG responses [41] correlate with poor disease outcomes. The gene discussed is IFNA1; the disease is COVID-19.